EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Sex-based differences in left ventricular mass reduction across angiotensin II receptor blockers in patients with heart failure with preserved or mildly reduced ejection fraction

Masashi Amano, Chisato Izumi, Shin Ito, Masafumi Kitakaze

Heart and Vessels · 2025-02 · 40 (2) · 100-110

DOI: 10.1007/s00380-024-02446-x ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Heart and Vessels, online erschienen am 30.07.2024. Verfasst von Masashi Amano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Heart Failure and Transplant, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan. m.aman…. Hauptthemen laut MEDLINE: Angiotensin II Type 1 Receptor Blockers, Angiotensin Receptor Antagonists, Heart Failure, Hypertrophy, Left Ventricular. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Takeda Pharmaceutical Company Limited..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin II Type 1 Receptor BlockersAngiotensin Receptor AntagonistsHeart FailureHypertrophy, Left VentricularStroke VolumeAgedFemaleHumansMaleMiddle AgedBenzimidazolesBiphenyl CompoundsEchocardiographyHeart VentriclesOxadiazolesSex FactorsTetrazolesTime FactorsTreatment OutcomeVentricular Function, LeftVentricular Remodeling

Stichwörter der Autor:innen

AzilsartanCandesartanCardiovascular eventFemaleMale

Substanzen

Angiotensin II Type 1 Receptor BlockersAngiotensin Receptor AntagonistsazilsartanBenzimidazolesBiphenyl CompoundscandesartanOxadiazolesTetrazoles

Autor:innen und Institutionen

  • Department of Heart Failure and Transplant, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan. m.amano@ncvc.go.jp.
  • Department of Heart Failure and Transplant, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.
  • Department of Clinical Medicine and Development, National Cerebral and Cardiovascular Center, Osaka, Japan.
  • Department of Cardiovascular Medicine, Hanwa Memorial Hospital, Osaka, Japan.
  • The Osaka Medical Research Foundation for Intractable Diseases, Osaka, Japan.

Förderung

  • Takeda Pharmaceutical Company Limited.

Zitieren

APA

Amano, M., Izumi, C., Ito, S., & Kitakaze, M. (2025). Sex-based differences in left ventricular mass reduction across angiotensin II receptor blockers in patients with heart failure with preserved or mildly reduced ejection fraction. Heart and Vessels, 40(2), 100-110. https://doi.org/10.1007/s00380-024-02446-x

Vancouver

Amano M, Izumi C, Ito S, Kitakaze M. Sex-based differences in left ventricular mass reduction across angiotensin II receptor blockers in patients with heart failure with preserved or mildly reduced ejection fraction. Heart and Vessels. 2025;40(2):100-110. doi:10.1007/s00380-024-02446-x

BibTeX
@article{Amano2025,
  author = {Amano, Masashi and Izumi, Chisato and Ito, Shin and Kitakaze, Masafumi},
  title = {Sex-based differences in left ventricular mass reduction across angiotensin II receptor blockers in patients with heart failure with preserved or mildly reduced ejection fraction},
  journal = {Heart and Vessels},
  year = {2025},
  volume = {40},
  number = {2},
  pages = {100--110},
  doi = {10.1007/s00380-024-02446-x}
}
Kostenlos starten →